home › event - sensitive location and characterization of circulating tumor cells for improving therapy selection and monitoring treatment efficacy

EVENT:

Sensitive location and characterization of circulating tumor cells for improving therapy selection and monitoring treatment efficacy
Conferences & Talks

NCI Translates: NCI Translational Science Meeting

8 November 2008
Washington, D.C., USA

 

description

For metastatic disease, biomarker profiling of distant metastases is done only when feasible because biopsy of metastases is invasive and associated with potential morbidity without proven benefit. So although biomarker expression may differ in distant metastases, treatment with targeted therapies is almost always based on biomarker targets derived from a patient¹s primary breast tumor, usually excised years before development of metastatic disease. Circulating tumor cells (CTCs) in the blood have been linked to disease outcome in patients with metastatic breast cancer...We have developed a sensitive CTC detection tool using Fiber Array Scanning Technology (FAST) that can rapidly locate CTCs on a substrate and uses abundant cytokeratins not EpCAM as targets. We have developed a protocol that enables testing for protein expression of 5 markers in addition to the ones needed for CTC identification.

 

upcoming events   view all 

The Future of Making Things and the Business of Breakthroughs
Stephen Hoover, Keynote Speaker
21 April 2015 - 22 April 2015 | Montreal, Canada
Conferences & Talks  

Disruptive Technologies in Manufacturing (Opening Keynote)
Stephen Hoover
28 April 2015 | Seattle, WA
Conferences & Talks  

The First Five Kilobytes are the Hardest
George Dyson
29 April 2015 | George E. Pake Auditorium, PARC
PARC Forum  

Printed Hybrid Logic Circuits
Janos Veres
29 April 2015 | Berlin, Germany
Conferences & Talks  

IoT User Experience Design
Mike Kuniavsky
12 May 2015 | San Francisco, CA
Conferences & Talks